Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase

Xenobiotica

Volumn 30, Issue 3, 2000, Pages 253-261

  Lewis, A J ^a   Otake, Y ^a   Walle, U K ^a   Walle, T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORENYLACETOHYDROXAMIC ACID; RECOMBINANT ENZYME; SULFOTRANSFERASE;

ARTICLE; CHEMICAL MODIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CYTOSOL;

EID: 0034027689     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982500237640     Document Type: Article

References (37)

1. Abu-Zeid, M., Yamazoe, Y., and Kato, R., 1992, Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animals. Carcinogenesis, 13, 1307-1314.
2. Anderson, R. J., and Weinshilboum, R. M., 1980, Phenolsulphotransferase in human tissue: radio-chemical enzymatic assay and biochemical properties. Clinica et Chimica Acta, 103, 79-90.
3. Bamforth, K. J., Dagliesh, K. and Coughtrie, M. W. H., 1992, Inhibition of human liver steroid sulfotransferase activities by drugs: a novel mechanism of drug toxicity? European Journal of Pharmacology - Environmental Toxicology and Pharmacology Section, 228, 15-21.
4. Campbell, N. R. C., Van Loon, J. A. and Weinshilboum, R. M., 1987, Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochemical Pharmacology, 36, 1435-1446.
5. Chou, H.-C., Lang, N. P. and Kadlubar, F. F., 1995, Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Research, 55, 525-529.
6. Comer, K. A. and Falany, C. N., 1992, Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal. Molecular Pharmacology, 41, 645-651.
7. DeBaun, J.R., Smith, J. Y. R., Miller, E. C. and Miller, J. A., 1970, Reactivity in vivo of the carcinogen N-hydroxy-2-acetylaminofluorene: increase by sulfate ion. Science, 167, 184-186.
8. Duffel, M. W., Binder, T. P. and Rao, S. I., 1989, Assay of purified aryl sulfotransferase suitable for reactions yielding unstable sulfuric acid esters. Analytical Biochemistry, 183, 320-324.
9. Falany, C. N., 1991, Molecular enzymology of human liver cytosolic sulfotransferases. Trends in Pharmacological Sciences, 12, 255-259.
10. Falany, C. N., Comer, K. A., Dooley, T. P. and Glatt, H., 1995a, Human dehydroepiandrosterone sulfotransferase - purification, molecular cloning, and characterization. Annals of the New York Academy of Sciences, 774, 59-72.
11. Falany, C. N., Krasnykh, V. and Falany, J. L., 1995b, Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase. Journal of Steroid Biochemistry and Molecular Biology, 52, 529-539.
12. Falany, C. N., Vazquez, M. E. and Kalb, J. M., 1989, Purification and characterization of human liver dehydroepiandrosterone sulfotransferase. Biochemical Journal, 260, 641-646.
13. Falany, C. N., Wheeler, J., Oh, T. S. and Falany, J. L., 1994, Steroid sulfation by expressed human cytosolic sulfotransferases. Journal of Steroid Biochemistry and Molecular Biology, 48, 369-375.
14. Foldes, A. and Meek, J. L., 1973, Rat brain phenolsulfotransferase - partial purification and some properties. Biochimica et Biophysica Acta, 327, 365-374.
15. Ganguly, T. C., Krasnykh, V. and Falany, C. N., 1995, Bacterial expression and kinetic characterization of the human monoamine-sulfating form of phenol sulfotransferase. Drug Metabolism and Disposition, 23, 945-950.
16. Gilissen, R. A. H. J., Bamforth, K. J., Stavenuiter, J. F. C., Coughtrie, M. W. H. and Meerman, J. H. N., 1994, Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases. Carcinogenesis, 15, 39-45.
17. Gilissen, R. A. H. J., Ringer, D. P., Stavenuiter, H. J. F. C., Mulder, G. J. and Meerman, J. H. N., 1992, Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV. Carcinogenesis, 13, 1699-1703.
18. Glatt, H., Pauly, K., Czich, A., Falany, J. L. and Falany, C. N., 1995, Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed in Escherichia coli. European Journal of Pharmacology, 293, 173-181.
19. Heflich, R. H. and Neft, R. E., 1994, Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites. Mutation Research, 318, 73-174.
20. Hernández, J. S., Watson, R. W. G., Wood, T. C. and Weinshilboum, R. M., 1992, Sulfation of estrone and 17β-estradiol in human liver: catalysis by thermostable phenol sulfotransferase and by dehydroepiandrosterone sulfotransferase. Drug Metabolism and Disposition, 20, 413-422.
21. Laemmli, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
22. Lewis, A. J., Kelly, M. M., Walle, U. K., Eaton, E. A., Falany, C. N. and Walle, T., 1996, Improved bacterial expression of the human P form phenolsulfotransferase: applications to drug metabolism. Drug Metabolism and Disposition, 24, 1180-1185.
23. Lewis, A. J., Walle, U. K., King, R. S., Kadlubar, F. F., Falany, C. N. and Walle, T., 1998, Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells. Carcinogenesis, 19, 2049-2053.
24. Michejda, C. J. and Kroeger Koepke, M. B., 1994, Carcinogen activation by sulfate conjugate formation. Advances in Pharmacology, 27, 331-363.
25. Miller, J. A. and Surh, Y.-J., 1994, Sulfonation in chemical carcinogenesis. In F. C. Kauffman (ed.), Conjugation - Deconjugation Reactions in Drug Metabolism and Toxicity (Berlin: Springer), 112, pp. 429-457.
26. Oemar, B. S., Foellmer, H. G., Hodgdon-Anandant, L. and Rosenzweig, S. A., 1991, Regulation of insulin-like growth factor I receptors in diabetic mesangial cells. Journal of Biological Chemistry, 266, 2369-2373.
27. Otterness, D. M., Wieben, E. D., Wood, T. C., Watson, R. W. G., Madden, B. J., McCormick, D. J. and Weinshilboum, R. M., 1992, Human liver dehydroepiandrosterone sulfotransferase: molecular cloning and expression of cDNA. Molecular Pharmacology, 41, 865-872.
28. Ozawa, S., Chou, H.-C., Kadlubar, F. F., Nagata, K., Yamazoe, Y. and Kato, R., 1994, Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-expressed human and rat arylsulfotransferases. Japanese Journal of Cancer Research, 85, 1220-1228.
29. Ozawa, S., Tang, Y.-M., Yamazoe, Y., Kato, R., Lang, N. P. and Kadlubar, F. F., 1998, Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chemico-Biological Interactions, 109, 237-248.
30. Pacifici, G. M., Temellini, A., Castiglioni, M., D'Alessandro, C., Ducci, A. and Giuliani, L., 1994, Interindividual variability of the human hepatic sulphotransferases. Chemico-Biological Interactions, 92, 219-231.
31. Plager, J. E., 1965, The binding of androsterone sulfate, etiocholanolone sulfate, and dehydro-isoandrosterone sulfate by human plasma protein. Journal of Clinical Investigation, 44, 1234-1239.
32. Sharp, S., Barker, E. V., Coughtrie, M. W. H., Lowenstein, P. R. and Hume, R., 1993, Immuno-chemical characterisation of a dehydroepiandrosterone sulfotransferase in rats and humans. European Journal of Biochemistry, 211, 539-548.
33. Song, W.-C., Qian, Y. and Li, A. P., 1998, Estrogen sulfotransferase expression in the human liver: marked interindividual variation and lack of gender specificity. Journal of Pharmacology and Experimental Therapeutics, 284, 1197-1202.
34. Walle, T. and Walle, U. K., 1990, Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol. British Journal of Clinical Pharmacology, 30, 127-133.
35. Walle, U. K., Pesola, G. R. and Walle, T., 1993, Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. British Journal of Clinical Pharmacology, 35, 413-418.
36. Watabe, T., Hiratsuka, A. and Ogura, K., 1987, Sulphotransferase-mediated covalent binding of the carcinogen 7,12-dihydroxymethylbenz[a]anthracene to calf thymus DNA and its inhibition by glutathione transferase. Carcinogenesis, 8, 445-453.
37. Wood, T. C., Her, C., Aksoy, I., Otterness, D. M. and Weinshilboum, R. M., 1996, Human dehydroepiandrosterone sulfotransferase pharmacogenetics: quantitative Western analysis and gene sequence polymorphisms. Journal of Steroid Biochemistry and Molecular Biology, 59, 467-478.